Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.35
+0.280013.53%
Post-market: 2.31-0.0400-1.70%19:59 EDT
Volume:260.95K
Turnover:597.82K
Market Cap:39.67M
PE:-1.11
High:2.41
Open:2.09
Low:2.08
Close:2.07
Loading ...

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (Iv Ketamine) for the Treatment of Suicidal Depression

THOMSON REUTERS
·
30 Dec 2024

NRX Pharmaceuticals Inc - Completion of Nda Filing Expected in Q1 2025

THOMSON REUTERS
·
30 Dec 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression

PR Newswire
·
30 Dec 2024

New Strong Buy Stocks for December 30th

Zacks
·
30 Dec 2024

New Strong Buy Stocks for December 26th

Zacks
·
26 Dec 2024

New Strong Buy Stocks for December 24th

Zacks
·
24 Dec 2024

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024

PR Newswire
·
26 Nov 2024

NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Nov 2024

BRIEF-NRx Pharmaceuticals Announces Publication Of Paper Entitled "Quality Assurance Of Depression Ratings In Psychiatric Clinical Trials"

Reuters
·
25 Nov 2024

NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"

THOMSON REUTERS
·
25 Nov 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"

PR Newswire
·
25 Nov 2024

NRX Pharmaceuticals Inc (NRXP) Q3 2024 Earnings Call Highlights: Significant Reduction in ...

GuruFocus.com
·
19 Nov 2024

NRx Pharmaceuticals names Michael Abrams as CFO

TIPRANKS
·
19 Nov 2024

NRX Pharmaceuticals Inc - Interim-CFO Richard Narido to Focus on Hope Therapeutics Acquisitions

THOMSON REUTERS
·
19 Nov 2024

NRX Pharmaceuticals (Nasdaq:Nrxp) Appoints Michael Abrams as Chief Financial Officer

THOMSON REUTERS
·
19 Nov 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer

PR Newswire
·
19 Nov 2024